Eraxis Approval History
FDA Approved: Yes (First approved February 17, 2006)
Brand name: Eraxis
Generic name: anidulafungin
Dosage form: Injection
Company: Pfizer Inc.
Treatment for: Candidemia
Eraxis (anidulafungin) is an antifungal medicine of the echinocandin class, indicated for the treatment of candidemia and other forms of Candida infections (intra-abdominal abscess, and peritonitis) and esophageal candidiasis.
Development History and FDA Approval Process for Eraxis
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.